Athens, 22/3/2026
The MEDLINE Company announces its collaboration with Curaway for the exclusive distribution of Irreversible Electroporation (IRE) technology in Greece and Cyprus.
This collaboration combines the clinical expertise of The MEDLINE Company in the field of medical technology with Curaway’s innovation, aiming to advance modern interventional therapeutic approaches.
Irreversible Electroporation (IRE) is a non-thermal local catalysis technique based on the application of high voltage pulses to induce permanent disruption of the cell membrane and induce cell death by apoptosis. Unlike thermal methods, IRE preserves the integrity of the extracellular layer, allowing the preservation of critical structures such as vessels, bile ducts and nerve bundles.
Indications include:
– Liver tumors (primary and metastatic)
– Pancreatic cancer, particularly locally advanced unresectable cases
– Renal tumors
– Prostate cancer
– Soft tissue tumors in anatomically challenging locations
This technology offers significant advantages in treating tumors located near vital structures.
The MEDLINE Company and Curaway remain committed to advancing innovative technologies that improve clinical outcomes and elevate patient care.
Kind regards,
The Medline Company
